Lam RW

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.

3 papers · ORCID

ArticleKetamine

Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.

Gutierrez G, Vazquez G, Ravindran N +8

Europe PMC2025
ArticleKetamine

IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression.

Gutierrez G, Swainson J, Ravindran N +10

Europe PMC2024
ArticlePsilocybin

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.

Rosenblat JD, Husain MI, Lee Y +18

Europe PMC2023